Thursday, November 5, 2026||
MultiKhabarMultiKhabar

India proposes immediate suspension of drug manufacturing licences over quality failures

Share:WhatsAppFacebookX (Twitter)Telegram
India proposes immediate suspension of drug manufacturing licences over quality failures
Photo / Coverage: The Hindu Business Line
EXECUTIVE SUMMARY

The proposed changes seek to prevent substandard medicines from remaining in circulation while manufacturers address quality failures and regulatory concerns

Key Takeaways

  • India proposes immediate suspension of drug manufacturing licences over quality failures.

The proposed changes seek to prevent substandard medicines from remaining in circulation while manufacturers address quality failures and regulatory concerns

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on The Hindu Business Line

Visit Publisher Site →

Related News

🇮🇳 India
Tyre margins skid on costly rubber, firms mull more price hikes
Economy & Business29m ago

Tyre margins skid on costly rubber, firms mull more price hikes

JK Tyres’ earnings before interest, tax, depreciation and amortization (Ebitda) fell 36% year-on-year to ₹343 crore in the September quarter, while profit after tax fell 73% to ₹60 crore. Ceat saw its Ebitda slip 11% to ₹452 crore and profit down 40% from a year ago to ₹112 crore.

Livemint - News
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play